In the current study, we investigated the effect of VPA treatment on the K562 cell line, a model for CML, at the cell level using the Annexin-V/PI dual staining method and genome-wide expression and AS levels using exon microarray. Here, ANXA5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.